INS and metabolic dysfunction-associated steatotic liver disease: Improved insulin sensitivity plays a key role in the management of NAFLD as the dysfunction of the insulin pathway causes the flow of FAs to the liver, increases TG synthesis and storage, inflammation, steatosis, and oxidative stress in the body [79].